Generic name:cyclosporine (ophthalmic route) [ sye-kloe-SPOR-een ]
Drug class:Ophthalmic anti-inflammatory agents
Medically reviewed by Drugs.com. Last updated on Apr 22, 2022.
Commonly used brand name(s)
In the U.S.
- Cequa
- Restasis
- Restasis Multidose
- Verkazia
Available Dosage Forms:
- Solution
- Emulsion
Therapeutic Class: Ophthalmologic Agent
Pharmacologic Class: Calcineurin Inhibitor
Uses for Verkazia
Cyclosporine eye drops are used to increase tear production in patients who have a certain eye condition (eg, keratoconjunctivitis sicca). It is also used to treat vernal keratoconjunctivitis (allergic eye condition). This medicine belongs to a class of medicines known as immunosuppressants.
This medicine is available only with your doctor's prescription.
Before using Verkazia
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of Cequa™ in children or Restasis ™ in children younger than 16 years of age. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Verkazia® in children 4 years of age and older. Safety and efficacy have been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of Cequa™ or ...
